-
MDA 2026: More dietary protein linked to better lower limb function in MD
Eating more protein was associated with better lower limb function and a higher quality of
-
Clinical Study Alert: Phase 1 Study of MyoPAXon in Boys with DMD
Researchers at the University of Minnesota are seeking boys with Duchenne muscular dystrophy (DMD) to participate
-
Brogidirsen (NS-089/NCNP-02) 4.5-Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy (DMD) Presented at 2026 MDA Clinical & Scientific Conference.
NS Pharma, Inc. presented 4.5-year safety and efficacy data based on the open-label extension study
-
Dyne reports cardiopulmonary benefits in Duchenne trial of z-rostudirsen in individuals amenable to skipping exon 51
As an early investor in Dyne Therapeutics, CureDuchenne is happy to share that new analyses
-
Long-term AGAMREE data indicates continued effectiveness with clinically meaningful safety advantages over classic corticosteroids
Santhera Pharmaceuticals announced results from the ongoing Guardian study in Duchenne, and showed that AGAMREE
-
In Case You Missed It…
Quest Media is an innovative, adaptive lifestyle platform from MDA. With the power of this
-
MDA Awards Honors Those Driving Progress in Neuromuscular Research and Care
Each year, MDA presents awards to recognize people who are making a lasting impact on
-
PPMD Partners with Cooperative International Neuromuscular Research Group, Global Sponsors to Advance Expanded Duchenne Natural History Study
PPMD is proud to share our partnership with the Cooperative International Neuromuscular Research Group (CINRG)
-
MDA Ambassador Guest Blog: Redefining How I View Myself
Stephanie Chicas is 32 years old and lives in Alexandria, VA. Stephanie has SELENON congenital
-
What’s on my wish list for my family’s Duchenne dream home
My family needs more space. I wrote about this recently, and we have since decided
